[1] Syed FA, Oursler MJ, Hefferanm TE, et al. Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women[J]. Osteoporos Int, 2008, 19(9):1323-1330.
[2] Pepelassi E, Nicopoulou-Karayianni K, Archontopoulou AD, et al. The relationship between osteoporosis and periodontitis in women aged 45-70 years[J]. Oral Dis, 2012, 18(4):353-359.
[3] Wang CJ, McCauley LK. Osteoporosis and periodontitis[J]. Curr Osteoporos Rep, 2016, 14(6):284-291.
[4] Mau LP, Kuan YC, Tsai YC, et al. Patients with chronic periodontitis present increased risk for osteoporosis: A population-based cohort study in Taiwan[J]. J Periodont Res, 2017, 52(5): 922-929.
[5] Ming LG, Chen KM, Xian CJ. Functions and action mechanisms of flavonoids genistein and icariin in regulating bone remodeling[J]. J Cell Physiol, 2013, 228(3):513-521.
[6] An J, Yang H, Zhang Q, et al. Natural products for treatment of osteoporosis: the effects and mechanisms on promoting osteoblast-mediated bone formation[J]. Life Sci, 2016, 147:46-58.
[7] Rosen CJ, Bouxsein ML. Mechanisms of disease: is osteoporosis the obesity of bone[J]? Nat Clin Pract Rheumatol, 2006, 2(1):35-43.
[8] Lecka-Czernik B, Stechschulte LA. Bone and fat: a relationship of different shades[J]. Arch Biochem Biophys, 2014, 561: 124-129.
[9] Sui BD, Hu CH, Zheng CX, et al. Microenvironmental views on mesenchymal stem cell differentiation in aging[J]. J Dent Res, 2016, 95(12):1333-1340.
[10] Kokabu S, Lowery JW, Jimi E. Cell fate and differentiation of bone marrow mesenchymal stem cells[J]. Stem Cells Int, 2016, 2016:3753581.
[11] Liu H, Xiong Y, Zhu X, et al. Icariin improves osteoporosis, inhibits the expression of PPARγ, C/EBPα, FABP4 mRNA, N1ICD and jagged1 proteins, and increases Notch2 mRNA in ovariectomized rats[J]. Exp Ther Med, 2017, 13(4):1360-1368.
[12] Ye Y, Jing X, Li N, et al. Icariin promotes proliferation and osteogenic differentiation of rat adipose-derived stem cells by activating the RhoA-TAZ signaling pathway[J]. Biomed Pharmacother, 2017, 88:384-394.
[13] Zhang S, Feng P, Mo G, et al. Icariin influences adipogenic differentiation of stem cells affected by osteoblast-osteoclast co-culture and clinical research adipogenic[J]. Biomed Pharmacother, 2017, 88:436-442.
[14] 宋鹏, 王鸣刚, 姚娟, 等. 淫羊藿苷对rBMSCs成骨和成脂分化的影响[J]. 中国实验方剂学杂志, 2012, 18(20):200-204.
[15] 刘洪江, 刘海全, 秦佳佳. 不同浓度淫羊藿含药血清干预骨髓基质干细胞的成脂分化[J]. 中国组织工程研究与临床康复, 2011, 15(14):2583-2586.
[16] 张金娟, 文娱, 张贵林, 等. 淫羊藿苷对骨质疏松模型小鼠骨组织形态计量学指标的影响[J]. 贵州医药, 2010, 34(5):404-405.
[17] 成魁, 葛宝丰, 甄平, 等. 口服淫羊藿苷可提高大鼠的峰值骨密度和骨质量[J]. 中国骨质疏松杂志, 2014, 20(2):120-124.
[18] Jensen LB, Vestergaard P, Hermann AP, et al. Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish osteoporosis prevention study[J]. J Bone Miner Res, 2003, 18(2):333-342.
[19] 李华珠, 黄文秀, 杜志斌, 等. 淫羊藿对骨质疏松大鼠骨代谢影响的实验研究[J]. 口腔颌面外科杂志, 2010, 20(2):136-140.
[20] Li Y, Jin D, Xie W, et al. PPAR-γ and wnt regulate the differentiation of MSCs into adipocytes and osteoblasts respectively[J]. Curr Stem Cell Res Ther, 2018, 13(3): 185-192.
[21] Chen W, Zhu G, Hao L, et al. C/EBPα regulates osteoclast lineage commitment[J]. Proc Natl Acad Sci U S A, 2013, 110(18):7294-7299.
[22] 李庆帆, 王佐林. ALP、Runx2及OCN在大鼠拔牙后牙槽骨来源BMSCs中的表达[J]. 口腔颌面外科杂志, 2017, 27(2): 77-82.
[23] Qian G, Zhang X, Lu L, et al. Regulation of Cbfa1 expression by total flavonoids of herba epimedii[J]. Endocr J, 2006, 53(1):87-94.
|